Evaluation of Dopamine D-2 Receptor Occupancy by Clozapine, Risperidone, and Haloperidol In Vivo in the Rodent and Nonhuman Primate Brain Using 18F-Fallypride
暂无分享,去创建一个
Jogeshwar Mukherjee | Bradley T Christian | Bingzhi Shi | Joseph Mantil | B. Christian | J. Mukherjee | B. Shi | T. Narayanan | J. Mantil | Tanjore K Narayanan
[1] Peter J Ell,et al. Limbic selectivity of clozapine , 1997, The Lancet.
[2] S. Kasper,et al. IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol , 1997, Psychopharmacology.
[3] J S Fowler,et al. Measuring dopamine transporter occupancy by cocaine in vivo: Radiotracer considerations , 1998, Synapse.
[4] R. Rosenheck,et al. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. , 1997, The New England journal of medicine.
[5] J. Nilsson,et al. Dopamine D2 receptor binding sites for agonists. A tetrahedral model. , 1985, Molecular pharmacology.
[6] R E Harlan,et al. The accumbens: beyond the core-shell dichotomy. , 1997, The Journal of neuropsychiatry and clinical neurosciences.
[7] J. Lieberman,et al. Update on the clinical efficacy and side effects of clozapine. , 1991, Schizophrenia bulletin.
[8] B. Cohen,et al. Tissue Concentrations of Clozapine and its Metabolites in the Rat , 1993, Neuropsychopharmacology.
[9] G. Sedvall,et al. D1-, D2-, and 5-HT2-receptor occupancy in clozapine-treated patients. , 1994, The Journal of clinical psychiatry.
[10] S. Kapur,et al. Atypical antipsychotics: are some more atypical than others? , 2000, Psychopharmacology.
[11] Christer Halldin,et al. A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients , 1997, Psychopharmacology.
[12] J. Arnt,et al. Do Novel Antipsychotics Have Similar Pharmacological Characteristics? A Review of the Evidence , 1998, Neuropsychopharmacology.
[13] R. Sunahara,et al. Dopamine Receptors and Antipsychotic Drug Response , 1993, British Journal of Psychiatry.
[14] Chin-Tu Chen,et al. Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride. , 1999, Nuclear medicine and biology.
[15] B. Christian,et al. Quantitation of striatal and extrastriatal D‐2 dopamine receptors using PET imaging of [18F]fallypride in nonhuman primates , 2000, Synapse.
[16] N. Volkow,et al. Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors. , 1999, The Journal of pharmacology and experimental therapeutics.
[17] H. V. Van Tol,et al. Dopamine D2 and D4 receptor ligands: relation to antipsychotic action. , 1998, European journal of pharmacology.
[18] Christer Halldin,et al. Autoradiographic localization of extrastriatal D2‐dopamine receptors in the human brain using [125I]epidepride , 1996, Synapse.
[19] M. Laruelle. Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[20] Christer Halldin,et al. Distribution of D1- and D2-Dopamine Receptors, and Dopamine and Its Metabolites in the Human Brain , 1994, Neuropsychopharmacology.
[21] H. Meltzer,et al. The mechanism of action of novel antipsychotic drugs. , 1991, Schizophrenia bulletin.
[22] Robert M. Kessler,et al. Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride , 1993, Brain Research.
[23] L. Seiden,et al. Evaluation of d‐amphetamine effects on the binding of dopamine D‐2 receptor radioligand, 18F‐fallypride in nonhuman primates using positron emission tomography , 1997, Synapse.
[24] P. Seeman,et al. Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine. , 1999, The American journal of psychiatry.
[25] S. Kapur,et al. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. , 1999, The American journal of psychiatry.
[26] S. Kapur,et al. A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy. , 2000, Archives of general psychiatry.
[27] P. Seeman,et al. Complete Conversion of Brain D2 Dopamine Receptors from the High‐ to the Low‐Affinity State for Dopamine Agonists, Using Sodium Ions and Guanine Nucleotide , 1985, Journal of neurochemistry.
[28] L. Farde,et al. Non-equipotent doses partly explain differences among antipsychotics – implications of PET studies , 2000, Psychopharmacology.
[29] F. Bymaster,et al. Chapter 1 - Dopaminergic Approaches to Antipsychotic Agents , 1998 .
[30] Bernard Bendriem,et al. Quantitation of Extrastriatal D2 Receptors Using a Very High-Affinity Ligand (FLB 457) and the Multi-Injection Approach , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[31] A. Malhotra,et al. Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients. , 1996, The American journal of psychiatry.
[32] Nikolaus R. McFarland,et al. The Concept of the Ventral Striatum in Nonhuman Primates , 1999, Annals of the New York Academy of Sciences.
[33] P. Seeman,et al. Atypical Neuroleptics Have Low Affinity for Dopamine D2 Receptors or Are Selective for D4 Receptors , 1997, Neuropsychopharmacology.
[34] David J. Schlyer,et al. Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[35] N. Volkow,et al. Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[36] Robert B. Innis,et al. Kinetic and equilibrium analyses of [123I]epidepride binding to striatal and extrastriatal dopamine D2 receptors , 1999 .
[37] H. Meltzer,et al. An overview of the mechanism of action of clozapine. , 1994, The Journal of clinical psychiatry.